We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · April 14, 2021

Supreme DES With Early Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Implantation

Circulation

 

Additional Info

Disclosure statements are available on the authors' profiles:

Circulation
Novel SupremeTM DES With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial
Circulation 2021 Apr 06;[EPub Ahead of Print], AJ Lansky, DJ Kereiakes, A Baumbach, S Windecker, Y Hussain, C Pietras, O Dressler, O Issever, M Curtis, B Bertolet, JP Zidar, PC Smits, VA Jiménez Díaz, B McLaurin, S Hofma, Á Cequier, N Dib, E Benit, A Mathur, D Brogno, J Berland, J Wykrzykowska, G Piegari, S Brugaletta, S Saito, MB Leon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading